SEC Form 4 · accession 0000318154-26-000132
AMGEN INC · AMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles M Holley
Director
Period of report
Aug 7, 2026
Accepted (ET)
Aug 10, 2026 · 8:22 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000318154
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 7, 2026 | A | 103 | $0.00 | A | 12,990 | D | |
| Common Stock | holding | — | — | — | 1,260 | I | Holley Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares include 1,652 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.